Literature DB >> 12659573

Highly anti-selective SN2' substitutions of chiral cyclic 2-iodo-allylic alcohol derivatives with mixed zinc-copper reagents.

M Isabel Calaza1, Eike Hupe, Paul Knochel.   

Abstract

[reaction: see text] Functionalized allylic electrophilic reagents such as chiral 2-iodo-1-cyclohexenyl and -cyclopentenyl phosphates undergo highly stereoselective anti-S(N)2'-allylic substitution reactions with a wide range of organozinc reagents (R(2)Zn and RZnI) leading to chiral products with a transfer of the chiral information >95%. The use of functionalized organozinc iodides allows preparation of the bicyclic enones 8 and 9 in >or=93% ee.

Entities:  

Year:  2003        PMID: 12659573     DOI: 10.1021/ol0340742

Source DB:  PubMed          Journal:  Org Lett        ISSN: 1523-7052            Impact factor:   6.005


  6 in total

1.  SN2 versus SN2' Competition.

Authors:  Thomas Hansen; Pascal Vermeeren; Lea de Jong; F Matthias Bickelhaupt; Trevor A Hamlin
Journal:  J Org Chem       Date:  2022-06-24       Impact factor: 4.198

2.  An RCM strategy to stereodiverse delta-sultam scaffolds.

Authors:  María Jiménez-Hopkins; Paul R Hanson
Journal:  Org Lett       Date:  2008-05-01       Impact factor: 6.005

3.  Divalent and Multivalent Activation in Phosphate Triesters: A Versatile Method for the Synthesis of Advanced Polyol Synthons.

Authors:  Christopher D Thomas; James P McParland; Paul R Hanson
Journal:  European J Org Chem       Date:  2009-10-08

4.  A reductive cyclization approach to attenol A.

Authors:  Thomas E La Cruz; Scott D Rychnovsky
Journal:  J Org Chem       Date:  2007-03-09       Impact factor: 4.354

Review 5.  Asymmetric synthesis of naturally occurring spiroketals.

Authors:  B Rama Raju; Anil K Saikia
Journal:  Molecules       Date:  2008-08-28       Impact factor: 4.411

Review 6.  Practical Enantioselective Reduction of Ketones Using Oxazaborolidine Catalysts Generated In Situ from Chiral Lactam Alcohols.

Authors:  Yasuhiro Kawanami; Ryo C Yanagita
Journal:  Molecules       Date:  2018-09-20       Impact factor: 4.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.